Gerald Schmid
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- PARP inhibition in cancer therapy
- Transplantation top 10%
Papers in
-
- Cell death mechanisms and regulation 5
- DNA Repair Mechanisms 4
- Ubiquitin and proteasome pathways 3
- Retinoids in leukemia and cellular processes 2
- Oncology 17
- Cancer-related Molecular Pathways 15
- PARP inhibition in cancer therapy 6
- Co-authors
- Józefa Węsierska‐Gądek (12 shared papers)Christiane J. Bruns (4 shared papers)Karl‐Walter Jauch (4 shared papers)Markus Guba (4 shared papers)Christa Cerni (1 shared paper)Christian Graeb (3 shared papers)A. Papyan (3 shared papers)Ivan Ischenko (3 shared papers)
- Journals
- Journal of Cellular Biochemistry (10 papers)Biochemical and Biophysical Research Communications (2 papers)Expert Opinion on Investigational Drugs (1 paper)Molecular Neurobiology (1 paper)Blood (1 paper)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Gerald Schmid
27 papers receiving 900 citations
Peers
Comparison fields: 5 of 82
- Oncology 359
- Transplantation 33
- Cancer Research 126
- Molecular Biology 546
- Orthopedics and Sports Medicine 45
Countries citing papers authored by Gerald Schmid
This map shows the geographic impact of Gerald Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Schmid more than expected).
Fields of papers citing papers by Gerald Schmid
This network shows the impact of papers produced by Gerald Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Schmid. The network helps show where Gerald Schmid may publish in the future.
Co-authors
The 25 scholars most cited alongside Gerald Schmid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis. | 2003 | 118 |
| 2 | 2005 | 112 | |
| 3 | 1998 | 73 | |
| 4 | 1998 | 72 | |
| 5 | 1996 | 70 | |
| 6 | 2007 | 61 | |
| 7 | 2000 | 54 | |
| 8 | 2007 | 46 | |
| 9 | 2012 | 45 | |
| 10 | 2005 | 39 | |
| 11 | 2005 | 31 | |
| 12 | 2003 | 30 | |
| 13 | 2003 | 28 | |
| 14 | 2014 | 27 | |
| 15 | 1999 | 24 | |
| 16 | 2007 | 17 | |
| 17 | 2017 | 15 | |
| 18 | 2006 | 13 | |
| 19 | 2007 | 8 | |
| 20 | 2007 | 8 |
About Gerald Schmid
Gerald Schmid is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Cell Biology and Biotechnology, having authored 27 papers that have together received 922 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (15 papers), PARP inhibition in cancer therapy (6 papers), Cell death mechanisms and regulation (5 papers), DNA Repair Mechanisms (4 papers), Ubiquitin and proteasome pathways (3 papers), Microtubule and mitosis dynamics (3 papers), Cancer Research and Treatments (3 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Oncology (359 citations), Transplantation (33 citations), Cancer Research (126 citations), Molecular Biology (546 citations) and Orthopedics and Sports Medicine (45 citations). Gerald Schmid has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Józefa Węsierska‐Gądek, Christiane J. Bruns, Karl‐Walter Jauch, Markus Guba, Christa Cerni, Christian Graeb, A. Papyan, Ivan Ischenko, Jacek Wojciechowski and Maksim Yezhelyev. Their work appears in journals such as Journal of Cellular Biochemistry, Biochemical and Biophysical Research Communications, Expert Opinion on Investigational Drugs, Molecular Neurobiology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.